Mary Ann Liebert: Optimizing Tissue Engineering in Rotator Cuff Repair
March 19, 2024
March 19, 2024
NEW ROCHELLE, New York, March 19 -- Mary Ann Liebert Inc. issued the following news release:
Retear and failure to heal are significant post-operative complications in rotator cuff repair surgery despite the use of commercially available rotator cuff repair grafts. Advances in tissue engineering have demonstrated that mesenchymal stem cells (MSCs) and growth factors (GFs) enhance the regeneration of rotator cuff tendon-to-bone insertion in animal models, as described in an article p . . .
Retear and failure to heal are significant post-operative complications in rotator cuff repair surgery despite the use of commercially available rotator cuff repair grafts. Advances in tissue engineering have demonstrated that mesenchymal stem cells (MSCs) and growth factors (GFs) enhance the regeneration of rotator cuff tendon-to-bone insertion in animal models, as described in an article p . . .